共 133 条
[1]
Block GA(2004)Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2208-2218
[2]
Klassen PS(2006)Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study Kidney Int 70 351-357
[3]
Lazarus JM(2005)Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study Kidney Int 67 1179-1187
[4]
Ofsthun N(2006)Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients Kidney Int 70 771-780
[5]
Lowrie EG(2001)Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2131-2138
[6]
Chertow GM(2008)Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 52 519-530
[7]
Melamed ML(2003)Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy N Engl J Med 349 446-456
[8]
Eustace JA(2012)Efficacy and Safety of Paricalcitol Therapy for Chronic Kidney Disease: A Meta-Analysis Clin J Am Soc Nephrol 7 391-400
[9]
Plantinga L(2015)Effect of active vitamin D on cardiovascular outcomes in predialysis chronic kidney diseases: A systematic review and meta-analysis Nephrology 20 706-714
[10]
Young EW(2010)Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement Int J Surg 8 336-341